OBJECTIVES: The present study aimed to provide temporal information on material degradation and bone formation using composite (C) bone defect filler materials consisting of calcium phosphate cement (CaP) and poly(D,L-lactic-co-glycolic acid) (PLGA) microparticles (20 or 30 wt%) in rat critical-sized cranial defects. MATERIALS AND METHODS: Critical-sized bicortical cranial defects were created in 48 rats and CaP/PLGA cement composites were implanted for 4, 8 and 12 weeks (n=8). RESULTS: Histological analysis of the retrieved specimens revealed that implant degradation was significantly faster for C30% (remaining implant up to 89.4 ± 4.4% at 12 weeks) compared with C20% (remaining implant upto 94.8 ± 2.1% at 12 weeks), albeit that overall degradation was limited. Although bone formation was limited in both experimental groups (upto 685765.9 μm(2) for C20% vs. 917603.3 μm(2) for C30%), C30% showed a significant temporal increase of total bone formation. The percentage of defect bridging was comparable for C20% and C30% at all implantation periods (range 40 ± 25.5% at week 4 to 65 ± 20% at week 12 for C20%; range 51.8 ± 7.8% at week 4 to 70.5 ± 16.2% at week 12 for C30%). CONCLUSION: The amount of PLGA-microparticles in the CaP/PLGA cement composites demonstrated acceleration of material degradation, while bone formation was found not to be influenced. Further optimization of the composite material is necessary to increase control over degradation and tissue ingrowth.
OBJECTIVES: The present study aimed to provide temporal information on material degradation and bone formation using composite (C) bone defect filler materials consisting of calcium phosphate cement (CaP) and poly(D,L-lactic-co-glycolic acid) (PLGA) microparticles (20 or 30 wt%) in rat critical-sized cranial defects. MATERIALS AND METHODS: Critical-sized bicortical cranial defects were created in 48 rats and CaP/PLGA cement composites were implanted for 4, 8 and 12 weeks (n=8). RESULTS: Histological analysis of the retrieved specimens revealed that implant degradation was significantly faster for C30% (remaining implant up to 89.4 ± 4.4% at 12 weeks) compared with C20% (remaining implant upto 94.8 ± 2.1% at 12 weeks), albeit that overall degradation was limited. Although bone formation was limited in both experimental groups (upto 685765.9 μm(2) for C20% vs. 917603.3 μm(2) for C30%), C30% showed a significant temporal increase of total bone formation. The percentage of defect bridging was comparable for C20% and C30% at all implantation periods (range 40 ± 25.5% at week 4 to 65 ± 20% at week 12 for C20%; range 51.8 ± 7.8% at week 4 to 70.5 ± 16.2% at week 12 for C30%). CONCLUSION: The amount of PLGA-microparticles in the CaP/PLGA cement composites demonstrated acceleration of material degradation, while bone formation was found not to be influenced. Further optimization of the composite material is necessary to increase control over degradation and tissue ingrowth.
Authors: J R Parisi; K R Fernandes; I R Avanzi; B P Dorileo; A F Santana; A L Andrade; P R Gabbai-Armelin; C A Fortulan; E S Trichês; R N Granito; A C M Renno Journal: Mar Biotechnol (NY) Date: 2018-09-14 Impact factor: 3.619
Authors: P R Gabbai-Armelin; M T Souza; H W Kido; C R Tim; P S Bossini; A M P Magri; K R Fernandes; F A C Pastor; E D Zanotto; N A Parizotto; O Peitl; A C M Renno Journal: J Mater Sci Mater Med Date: 2015-04-17 Impact factor: 3.896
Authors: Manuela Ventura; Yi Sun; Viorel Rusu; Peter Laverman; Paul Borm; Arend Heerschap; Egbert Oosterwijk; Otto C Boerman; John A Jansen; X Frank Walboomers Journal: Tissue Eng Part C Methods Date: 2012-12-21 Impact factor: 3.056